News

WASHINGTON, D.C.  – This week, the House Committee on Energy and Commerce is holding two Subcommittee Hearings and one Full Committee Markup. Read more below.  SUBCOMMITTEE HEARING: The Energy and Commerce Subcommittee on Oversight and Investigations is holding a hearing on ensuring the nation’s organ procurement and transplant system prioritizes patient safety.  DATE: Tuesday, July 22, 2025  TIME: 10:15 AM ET  LOCATION: 2123 Rayburn House Office Building  SUBCOMMITTEE HEARING: The Energy and Commerce Subcommittee on Energy is holding a hearing on pipeline safety policy and will examine the reauthorization of the Pipeline and Hazardous Materials Safety Administration’s (PHMSA) pipeline safety program.   DATE: Tuesday, July 22, 2025  TIME: 10:30 AM ET  LOCATION: 2322 Rayburn House Office Building  FULL COMMITTEE MARKUP: The House Committee on Energy and Commerce will hold a markup of two bills.   DATE: Wednesday, July 23, 2025  TIME: 10:00 AM ET  LOCATION: 2123 Rayburn House Office Building ###

WASHINGTON, D.C.  – Congressman John Joyce (PA-13), Chairman of the Subcommittee on Oversight and Investigations, delivered the following opening statement at today’s hearing titled Ensuring Patient Safety: Oversight of the U.S. Organ Procurement and Transplant System . Subcommittee Chairman Joyce's opening statement as prepared for delivery: “Good morning, and welcome to today’s hearing entitled Ensuring Patient Safety: Oversight of the U.S. Organ Procurement and Transplant System. I want to begin this hearing by saying that it is an honor to serve as Chairman of this Subcommittee and I look forward to working on a bipartisan basis to shed light on many areas in need of oversight and reform. “Just last year, more than 48,000 organ transplants were performed in the United States. Many of us know someone who is an organ donor or organ recipient. They might be relatives. neighbors, friends, or coworkers. These procedures are often lifesaving and can extend an individual's life by years, if not decades. While organ transplants are a relief to so many families, there is another side of the story that is equally as important, that of the donors and their loved ones. “In September of last year, this Subcommittee held a hearing to conduct oversight of the organ transplant and procurement system, as well as implementation of the Securing the U.S. Organ Procurement and Transplantation Network Act, which was signed into law in September 2023. “During that hearing, certain allegations came to light, raising concerns whether practices and procedures were putting patient safety at risk. Following this hearing, the Health Resources and Services Administration, or HRSA, directed the Organ Procurement and Transplantation Network, or investigate this issue to better understand what transpired in one of these alleged incidents. “HRSA also conducted its own investigation. The agency compiled a report that describes practices at the organ procurement organization (OPO)—formerly known as the Kentucky Organ Donor Affiliates (KODA)—but is now known as Network for Hope. The report also details the failures by the OPO and the OPTN to adequately recognize and respond to poor patient care and quality practices. HRSA then issued a corrective action plan to the OPTN, directing them to take specific actions to address the concerns identified in the reviews. “I ask unanimous consent to enter HRSA's report, dated March 25, 2025, and HRSA's corrective action plan dated May 28, 2025, into the hearing record. Without objection so ordered. “The report provides a detailed overview of HRSA's investigation, including about what is referred to as the index case; additional cases that HRSA reviewed; actions taken by the OPTN, the OPTN contractor (UNOS), and KODA; and, finally, KODA's organ procurement in recent years. “As part of its review of the cases beyond the index case, HRSA focused on the overall medical presentation and initial and subsequent neurologic status of patients, staff interactions with patient families and primary medical teams, and evidence of robust documentation and quality assurance procedures. Lastly, the report includes an appendix consisting of OPTN's findings following the HRSA-directed review. “For every doctor, the most important tenet in the patient-physician relationship is above all, do no harm, but what happened in these cases fractured the physician-patient relationship and saw patients subjected to pain and suffering that never should have occurred. As Members of Congress, we all swore an oath to protect the Constitutional right to life afforded to all Americans. These incidents cannot be allowed to stand without strict investigation and oversight in the spirit of this Constitutional oath.   “The federal government plays a critical role in ensuring the organizations tasked with administering and overseeing our nation’s organ procurement and transplant system operate safely, effectively, and in accordance with the law. Transparency is key to improving the system and repairing public trust. This Committee has, and will continue, to follow the facts so that we can restore trust and accountability within the system.  “I want to thank the witnesses from both panels for joining us today. I look forward to hearing from each of you about the challenges facing the organ procurement and transplant system, the ways that the system can be improved, and how we can ensure the safety of all patients who elect to be organ donors.”  ###

WASHINGTON, D.C. – Today, Congressman John Joyce, M.D. (PA-13), Chairman of the Subcommittee on Oversight and Investigations, led a hearing titled Ensuring Patient Safety: Oversight of the U.S. Organ Procurement and Transplant System. “What happened in these cases cannot go without discussion and oversight. Transparency is key to improving the system and maintaining public trust,” said Chairman Joyce . “The federal government plays a critical role in ensuring the organizations tasked with administering and overseeing our nation’s organ procurement and transplant system operate safely, effectively, and in accordance with the law. This Committee has, and will continue, to follow the facts so that we can restore trust and accountability within the system.”   Watch the full hearing here . Below are key excerpts from today’s hearing: Chairman Brett Guthrie (KY-02): “We just need everybody here today—and both panels—to admit that we have issues we have to fix and not just point fingers. I think that's been a concern by some of us on our side of the dais, and I think both sides of the aisle. As you saw, the HRSA report that the OPO on the index case essentially said everything is working, and we know everything's not working—but we need everything to work—and it starts by acknowledging that we have a role in the process of fixing this. We need to admit we have issues. We need to admit there are issues that need to be fixed, and we need to come together and be constructive because I can tell you, as a son of someone that we were praying was going to have an opportunity to have an extended life, I've seen it. And there are families out there today in the same situation we were in.” Congressman Gary Palmer (AL-06): “The Association of Organ Procurement Organizations publicized an open letter characterizing the ongoing effort to improve patient safety through enhanced oversight as a ‘misinformation conspiracy campaign’ and concluded it is time to stop. Among the signatories to this letter were more than 20 UNOS staff signing with their corporate affiliation. Dr. McBride, did you sign that letter? ” Dr. Maureen McBride: “Yes, I did.” Congressman Gary Palmer (AL-06): “Why?” Dr. Maureen McBride: “Congressman, let me start off by saying that I disagree with the way that letter has been characterized.”   Congresswoman Kat Cammack (FL-03): “As everyone knows, this committee has been investigating corruption from organ contractors for more than a year. In fact, I was in the last hearing that we had on this, and it was quite a contentious hearing. One issue that's pretty close to my heart is ensuring equal access for life saving transplants for patients with disabilities. Just last month, the House passed a bipartisan bill that I was proud to lead alongside my friend and colleague, Debbie Dingell, to end organ transplant discrimination against individuals with disabilities. It is with total horror that I read a recent investigative report highlighting one of the most horrific cases of patient abuses. ” ###

WASHINGTON, D.C.  – Congressman Bob Latta (OH-05), Chairman of the Subcommittee on Energy, delivered the following opening statement at today’s hearing titled  Strengthening American Energy: A Review of Pipeline Safety Policy. Subcommittee Chairman Latta's opening statement as prepared for delivery: “Welcome to today’s hearing, “Strengthening American Energy: A Review of Pipeline Safety Policy.” And thank you to our witnesses for your participation. “Today, we will examine the Pipeline and Hazardous Materials Safety Administration’s (PHMSA) pipeline safety program. “PHMSA is a Department of Transportation agency tasked with developing and enforcing federal safety regulations for the nation’s onshore pipeline infrastructure and the transportation of hazardous materials. “The witnesses before us represent different segments of PHMSA’s regulated community and can provide important perspectives on the reauthorization of PHMSA. “Pipelines are the safest and most efficient mode of transportation for oil, natural gas, liquid energy products, and hazardous materials, and they play an instrumental role in delivering the products that drive our nation’s economy forward. “The agency has about 3.3 million miles of pipelines under its purview. In order to ensure these pipelines are operated in a safe and reliable manner, PHMSA partners and coordinates with States to administer pipeline safety programs and inspect infrastructure within a state's boundaries. “PHMSA was last authorized in the Protecting Our Infrastructure of Pipelines and Enhancing Safety Act (PIPES) of 2020, through Fiscal Year 2023. “I hope we can work in a bipartisan fashion this Congress with our House and Senate colleagues to reauthorize PHMSA to continue carrying out its mission and associated duties. This subcommittee has a responsibility to ensure PHMSA maintains a strong focus on safety and operates within its statutory authorities. “The PIPES Act of 2020 included several statutorily mandated rulemakings that never fully got out the door under the previous administration. Today, the subcommittee will examine implementation of the PIPES Act to ensure PHMSA is on track to carry out Congressional intent in a cost-effective and workable manner. “Additionally, the subcommittee will examine new challenges and opportunities for pipeline safety. “For example, the replacement of aging infrastructure must be a top priority for PHMSA, States, and pipeline operators, but it presents cost and operational challenges. “Especially as energy demand is projected to increase significantly in the immediate future, the upgrading of our natural gas network must be prioritized to ensure the safe transportation of natural gas and other important energy sources and products. “While substantial progress has been made in replacing aging pipes, there is still work to be done. I look forward to hearing from our witnesses on how PHMSA can best address the remaining 1 percent of iron distribution pipes. “American innovations and new technologies, like artificial intelligence technology, also present opportunities to bolster the quality of risk assessments and advance safety towards our collective goal of zero incidents. However, these technologies will also pose challenges to information and operational security. It is important that a PHMSA reauthorization gives the agency the tools needed to have an effective approach for the opportunities and challenges ahead.  “In his confirmation hearing last week, Paul Roberti, President Trump’s nominee for PHMSA administrator, committed to pursuing opportunities to utilize new, cost-effective technologies to enhance safety. The subcommittee hopes to collaborate with PHMSA and pipeline operators in this endeavor. “A PHMSA reauthorization must prioritize the improvement of the agency’s core responsibility: safety. I am concerned that the previous administration advanced extraneous priorities and set safety to the side. However, President Trump’s administration has recommitted to this critical mission, and I hope this Committee can produce a reauthorization that maintains safety as the cornerstone of PHMSA’s pipeline safety program. “Pipelines are imperative to public safety and the energy security of our nation. I look forward to hearing from pipeline operators today as we build on American energy leadership.”

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, issued the following statement after the Centers for Medicare & Medicaid (CMS) announced steps to remove 2.8 million duplicative enrollees in two or more Medicaid and/or ACA exchange plans.  “I applaud President Trump for taking decisive action to remove 2.8 million duplicative enrollees from State Medicaid programs and ACA exchanges, a move that will uphold the integrity of these programs by rooting out corrosive waste, fraud, and abuse,” said Chairman Guthrie . “This builds upon work by House Republicans in the OBBBA that gives tools to CMS and the States to prevent wasteful spending like this from happening again.”   Background:    According to CMS, a recent analysis of 2024 enrollment data identified 2.8 million Americans either enrolled in Medicaid or the Children’s Health Insurance Program (CHIP) in multiple states or simultaneously enrolled in both Medicaid/CHIP and a subsidized Affordable Care Act (ACA) Exchange plan.  Stopping duplicative enrollment in government health programs has the potential to save taxpayers approximately $14 billion annually.  As a result of the One Big Beautiful Bill Act , CMS now has new tools to prevent future incidences like that leads to the federal government paying twice for the same person’s care—saving billions and restoring integrity to the system.  ###

WASHINGTON, D.C. – In case you missed it, the Wall Street Journal Editorial Board wrote the following op-ed this week highlighting the need unleash reliable American energy including natural gas, oil, coal, hydropower, and nuclear, and discussing why subsidies for unreliable energy sources fail to meet the needs of American communities. Key Takeaways: Americans need reliable baseload power, not subsidized renewables that will fail to meet our energy needs. As energy demand increases, proven sources like natural gas, oil, coal, hydropower, and nuclear are the only way to ensure a reliable and stable energy grid. The Inflation Reduction Act increased subsidies for wind and solar in ways that have distorted energy investments. Because the subsidies can offset more than 50% of a project’s cost, solar and wind became more profitable to build than new baseload gas plants, which jeopardizes our grid. Power shortfalls are projected for 2030, with 104 gigawatts of baseload power being retired in the next five years. Even if that production is replaced, as planned, with solar and wind, shortfalls will still exist. Coal, nuclear and gas plants are still needed to back up solar and wind, but they cannot remain profitable if they are only operating part-time. As a result, many plants have been forced to close. In Case You Missed It… “Democrats are attacking the GOP’s budget bill for phasing out subsidies for wind and solar power, claiming this will cause power shortages and higher electric rates. The evidence suggests the opposite, as a new Energy Department study illustrates. “As we’ve been writing for years, the reliability of the U.S. electrical grid is in trouble. The Energy report projects potential power shortfalls in 2030, as 104 gigawatts of baseload power retire in the next five years. But here’s the really bad news: That shortfalls will exist even if that production is replaced, as expected, with 209 gigawatts of the mostly solar and wind generation under development. “Americans would lose power in 2030 for an average of 817.7 hours (34 days), assuming typical weather conditions. If heat waves or storms stress the grid, outages could reach 55 days. Even without plant shutdowns, Americans would lose power for 269.9 hours (11 days) amid demand growth. The power shortages would be worse in middle America, where demand is growing fastest owing to AI data centers and renewables are displacing coal and gas. “How can this be? The answer is that the Inflation Reduction Act turbo-charged subsidies for wind and solar in ways that are distorting energy investment. Because the subsidies can offset more than 50% of a project’s cost, solar and wind became more profitable to build than new baseload gas plants. The credits enable wind and solar to under-price coal and gas plants in competitive power markets. “Any wonder that solar, wind and batteries (which also qualify for IRA subsidies) are projected to make up 93% of new utility-scale electricity capacity this year? Coal, nuclear and gas plants are still needed to back up solar and wind, but they can’t make a profit running only some of the time. Thus many have been closing, jeopardizing grid reliability. “The renewable lobby claims that new gas plants can’t be built in time to meet rising power demand. Ergo, the argument goes, taxpayers must subsidize wind and solar to meet electric demand. But if what they say is true, why do wind and solar need subsidies? There will be a market incentive to build wind and solar anyway. “It’s true there’s a shortage of new gas turbines owing to surging global demand. But turbine manufacturers are expanding production, and the phaseout of the IRA tax credits will provide them with more certainty to make investments in new capacity. “Turbine makers expanded production in the early 2000s as demand for new gas plants rose, but they were left with excess capacity when demand weakened last decade. That was in part because federal subsidies and state renewable mandates encouraged utilities to procure power from solar and wind in lieu of gas. “Wind and solar projects also face long wait-times to connect to the grid—from four to nine years according to a recent study. The IRA increased delays by increasing the projects in the pipeline. So the phaseout of the tax credits could benefit renewable projects that don’t need subsidies to be economic. “ The claim that tax credits reduce electric rates is contradicted by experience. Wind and solar must be backed by peaker gas plants or batteries, which both cost more than three times as much as baseload power. Renewables also cause price spikes when there are power shortages, and they require more transmission investments to balance fluctuations in loads and frequencies. “All of this is why Texas’s residential power prices have risen some 40% over the last seven years. The renewable lobby says the financial benefits of the tax credits are passed onto electric customers, which may be true when state-regulated utilities build projects. But the credits usually pad the profits of independent generators. “The best way to make the grid reliable again is to let supply and demand work in energy markets without the distortions of mandates and subsidies. The GOP budget bill takes a step in that direction that should be welcomed.” ###

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman John Joyce (PA-13), Chairman of the Subcommittee on Oversight and Investigations, issued the following statement regarding findings from a Health Resources and Services Administration (HRSA) report outlining concerning patterns in our nation’s organ procurement and transplant system.  “ HRSA’s report contains shocking new information about practices and procedures that may put patients at risk of preventable harm in the organ procurement and transplant system,” said Chairmen Guthrie and Joyce. “The ‘index case,’ and others examined by HRSA in the report, are troubling example of threats to patient safety, and what has transpired within these cases cannot go without further analysis and investigation. Oversight and transparency are critical to both improving the system and maintaining public trust. This Committee will continue to engage in open discussions surrounding these systemic issues to protect patients and their families and restore faith in our nation’s organ procurement and transplant system.”   Click HERE to read the full agency report.   Click HERE to read the full corrective action plan.   Background:   The Energy and Commerce Subcommittee on Oversight and Investigations, led by Chairman John Joyce (PA-13), is holding a hearing titled Ensuring Patient Safety: Oversight of the U.S. Organ Procurement and Transplant System .   WHAT: Subcommittee on Oversight and Investigations hearing on ensuring the nation’s organ procurement and transplant system prioritizes patient safety.  DATE: Tuesday, July 22, 2025  TIME: 10:15 AM ET  LOCATION: 2123 Rayburn House Office Building ###

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, announced a Full Committee Markup of two bills.  WHAT: Full Committee Markup of Two Bills   DATE: Wednesday, July 23, 2025   TIME: 10:00 AM ET   LOCATION: 2123 Rayburn House Office Building This notice is at the direction of the Chairman. The markup will be open to the public and press and will be live streamed online at energycommerce.house.gov . If you have any questions concerning the hearing, please contact Jessica Donlon with the Committee staff at Jessica.Donlon@mail.house.gov . If you have any press-related questions, please contact Matt VanHyfte at Matt.Vanhyfte@mail.house.gov . Items to be considered:    H.R. 4312 , Student Compensation and Opportunity through Rights and Endorsements (SCORE) Act (Rep. Bilirakis, Bynum, Guthrie, Walberg, Jordan, Figures, McClain, Fitzgerald, and Fry)   H.R. 4273 , Over-the-Counter Monograph Drug User Fee Amendments (Reps. Latta and DeGette) ###

WASHINGTON, D.C.  – Congressman Morgan Griffith (VA-09), Chairman of the Subcommittee on Health, delivered the following opening statement at today’s hearing titled Legislative Proposals to Maintain and Improve the Public Health Workforce, Rural Health, and Over-the-Counter Medicines. Subcommittee Chairman Griffith’s opening statement as prepared for delivery: “Today’s legislative hearing is necessary to continue essential programs that are vital to our health care infrastructure.  “Many of the bills before us expire at the end of this fiscal year and must be reauthorized.   “One of the bills that will be discussed today is H.R. 4273, the Over-the-Counter Monograph Drug User Fee Amendments, led by Mr. Latta and Ranking Member DeGette.   “The Coronavirus Aid, Relief, and Economic Security (CARES) Act, which passed in 2020, modernized the regulation of over-the-counter monograph drugs and products. It also created a new user fee program to support this new framework, also known as OMUFA.   “Generally, a company can market an over-the-counter drug if they either submit a new drug application or go through the over-the-counter monograph process.   “Prior to 2020, this involved a lengthy, burdensome three-phase, rulemaking process.  “This led to Congress creating a new regulatory framework that allows FDA to issue administrative orders determining that a product is generally recognized as safe and effective, or GRASE, and simultaneously establishing a new user fee program to help ensure this process is effective and streamlined.   “This is the first reauthorization of OMUFA.  “We hope to work in a bipartisan way to address any outstanding issues to ensure this program is functioning how Congress initially intended, including minimizing regulatory burdens, supporting innovation, and increasing access to products in a safe and efficient manner.   “We will also consider other legislation that will help encourage the FDA to be more flexible in their review processes.   “H.R. 3686, the SAFE Sunscreen Standards Act, led by Dr. Joyce and Mrs. Dingell, would require the FDA to consider the use of certain real-world, evidence-based and non-animal testing methods when it comes to evaluating new sunscreen active ingredients in the United States.   “We are behind other countries in bringing innovative sunscreens to market, and this bill would help to bridge that gap.  “During our last hearing on OMUFA, we had a robust discussion around the need for more innovative sunscreens to be available in the United States.   “I look forward to the discussion around these policies today.  “Along similar lines, the FDA must keep pace with current technological advancements, which includes greater utilization of non-animal testing methods.   “H.R. 2821, led by Reps. Carter and Barragan, would help support FDA’s efforts to do just that.   “Congress gave FDA this ability in 2022 when the FDA Modernization 2.0 was signed into law, but the FDA has failed to fully implement these practices.   “This legislation would require the FDA to finally update its regulations to account for non-animal testing. “This bill does not require non-animal testing; it simply provides the option if companies wish to pursue less costly methods, such as computer AI modeling or organ chip testing.   “There are also two important reauthorizations in front of us today that serve a vital role in helping our medical workforce, which are the Title VII and Title VIII reauthorizations.   “These programs allocate resources for scholarships and educational assistance, so students from underserved backgrounds, who are often from rural areas, can pursue medical careers and help support the medical workforce that Americans widely rely upon.   “It is crucial for Congress to take a close look at these programs to ensure resources are going to areas and patients who need it most.  “We are also discussing legislation that will continue grants for certain health care services in rural areas and help to increase the use of telehealth, so patients can access care more easily.  “Reauthorizing the Telehealth Resource Centers Grant Program will support our telehealth infrastructure that has become a lifeline for both providers and patients across the country– especially in rural areas.   “Considering each of these reauthorizations is an important step forward to ensure each program is working as intended.  “I look forward to hearing from our witnesses today regarding the importance of these programs, and to ensure they are reauthorized in a timely manner.”   ###